leisure time -WSS

leisure time

author：focus 2025-10-01 01:00:01 - browse：974

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

The Food and Drug Administration on Thursday approved an Eli Lilly drug that takes a new approach to treating ulcerative colitis, a chronic inflammatory disease that can cause intense gastrointestinal pain and distress.

The therapy, dubbed Omvoh, is an antibody that blocks IL-23p19, an immune signaling molecule that plays a key role in sustaining the disease. It’s the first treatment to target this particular pathway in ulcerative colitis. The drug’s approval comes after two late-stage trials found that patients taking Omvoh showed a significant improvement in symptoms after both three months and a year compared with those given a placebo, and that the therapy had minimal side effects.

Omvoh’s list price will be $9,593 per month for intravenous delivery and $10,360 per dose injected beneath the skin. A company spokesperson told STAT that patients who have the drug covered by commercial insurance may pay as little as $5 per month for up to 30 months.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Orchard's therapy for neuron disease in children wins FDA approval

hotspot

WSS

U.K. researchers warn about biases in medical devices, algorithms

Stop the failed accountable care organization experiment

I was wrong about Geron's blood cancer drug. Now, is it a takeover target?

I was wrong about Geron's blood cancer drug. Now, is it a takeover target?

Contact tracing may help avoid another lockdown. Can it work in the U.S.?

Our daughter's deadly disease: trisomy 18. We wanted to protect her

hotspot

leisure time

hotspot

Medical records are filled with copy

New rules on organ donation and transplantation 'will bring chaos'

In age of alternative facts, a scholarly course on calling out crap

Contact tracing may help avoid another lockdown. Can it work in the U.S.?

Medical leaders decry Supreme Court decision on affirmative action

Organ transplantation is at a crossroads. Major reform is needed

Medicare proposal to cover medical devices draws a mixed reaction

SCOTUS questions limit to govt efforts to fight misinformation

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Caitlin Bernard's story shows physicians can't shy from advocacy

Wikipedia

Artificial intelligence advances fuel industry trying to preserve loved ones after death

Our daughter's deadly disease: trisomy 18. We wanted to protect her

Review: 'Barbie' will hit you like a shot in the heart

I was wrong about Geron's blood cancer drug. Now, is it a takeover target?

Marvel Studios reveals new trailer for 'The Marvels': Watch here

FDA official pushes for dedicated emerging pathogens team

focus

hotspot

Wikipedia

hotspot